Building with an innovation mindest, Neurophth is focused on new technologies (including gene therapy) and unmet medical needs, and actively committed to the global commercialization of all products.
As a fast-growing innovative biotech company, Neurophth is well positioned to:
Co-development and/or co-commercialization both in and outside of China
Accelerate process development, clinical development and commercialization under international quality standards
Enter the large China market with agile end-to-end strategy from R&D to commercialization
For partnership discussions, please contact：BD@neurophth.com